And That Happened: Monday's Scores and Highlights

9 Comments

Reds 6, Athletics 4: Wild. Francisco Cordero couldn’t hold a 2-1 lead in the ninth, giving up a Kevin Kouzmanoff homer to send it into extras. The Reds hit three dingers off the A’s pen in the tenth to take a 6-2 lead. Cordero then walked the first two A’s batters to start the bottom of the tenth and was yanked. The A’s end up having the bases loaded with no outs, but only score two — both on groundouts — and then Jack Cust whiffs to end the game. Thanks to the A’s massive failure, Cordero ends up getting what may be the least-deserved win by a pitcher this season.

Diamondbacks 10, Yankees 4: A.J. Burnett and his straight, deception-free fastball gets shelled by the Dbacks for seven runs on nine hits, leaving the outcome of this one without any doubt from the get-go.

Nationals 2, Royals 1: The Royals manage 11 hits but only one run thanks to two caught stealings, a pickoff and a couple of sacrifices. Viva small ball and everything, but you give away outs like that and you make even a tomato can like Livan Hernandez look good.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.